[79] analysed cfDNA in peripheral blood of 12 sarcoma patients using NGS, detecting structural variants in 50.0% (6/12) of plasma samples, including 5 fusion genes (Table 3) and one MDM2 amplification [79]. This evidence concerns the gene MDM2 and sarcoma.